The Molecular Jackhammer Cancer Therapeutics Institute is a nonprofit organization that supports the research and development of molecular jackhammers to accelerate the journey toward clinical trials for cancer eradication

Our Values

These core values guide our mission and shape our approach to therapeutic development.

Innovation & Scientific Excellence

We prioritize cutting-edge research and development, driving innovation to advance molecular jackhammer technology for cancer treatment.

Patient-Centered Focus

Our mission is rooted in improving patient outcomes. Every decision and effort we make is aimed at bringing life-saving therapeutics closer to clinical use.

Collaboration & Partnerships

We believe breakthroughs are achieved through teamwork. We foster strong collaborations with researchers, clinicians, and organizations to accelerate our mission.

Integrity & Transparency

We operate with honesty and openness, ensuring ethical research practices, responsible stewardship of resources.

Urgency & Determination

Time is critical in the fight against cancer. We act with a sense of urgency, relentless determination, and dedication to eradicating cancer through innovative therapies.

Education & Awareness

We are committed to raising awareness of our therapeutic advancements and educating the public and scientific community about our mission and progress.

Inclusivity & Accessibility

We strive to ensure that future molecular jackhammer therapies are developed with equitable access in mind, addressing the needs of diverse patient populations.

Our History

A journey of innovation and dedication in therapeutic development.

2021

Initial Discovery

Initial discovery of Molecular Jackhammers.

2023

Nature Chemistry Publication

Publication of Molecular Jackhammer technology in Nature Chemistry, garnering worldwide attention.

2024

Technology Enhancement & Universal Cancer Treatment

Development of improved and more potent Molecular Jackhammers, which demonstrated to be effective against all tested cancers.

2025

Institute Establishment

Establishment of the Molecular Jackhammers Cancer Therapeutics Institute.